Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Alnylam Pharmaceuticals Inc (NASDAQ:ALNY)

60.38
BATS BZX Real-Time Price
As of 1:54pm ET
 -5.21 / -7.94%
Today’s Change
59.50
Today|||52-Week Range
140.00
-35.86%
Year-to-Date
No recent news for Alnylam Pharmaceuticals Inc.

Today’s Trading

Previous close65.59
Today’s open64.14
Day’s range59.50 - 64.93
Volume676,199
Average volume (3 months)964,974
Market cap$5.6B
Dividend yield--
Data as of 1:54pm ET, 02/08/2016

Growth & Valuation

Earnings growth (last year)-234.48%
Earnings growth (this year)+31.23%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+7.20%
P/E ratioNM
Price/Sales142.50
Price/Book5.41

Competitors

 Today’s
change
Today’s
% change
IONSIonis Pharmaceutical...-3.41-9.64%
QQuintiles Transnatio...-1.91-3.32%
ICLRICON PLC-2.01-2.98%
CRLCharles River Labora...-3.86-5.51%
Data as of 1:55pm ET, 02/08/2016

Financials

Next reporting dateFebruary 12, 2016
EPS forecast (this quarter)-$0.94
Annual revenue (last year)$50.6M
Annual profit (last year)-$360.4M
Net profit margin-712.79%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
John M. Maraganore
President &
Chief Operating Officer
Barry E. Greene
Corporate headquarters
Cambridge, Massachusetts

Forecasts

Partner Offers